The global demand for Chronic Back Pain Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Chronic back pain is referred to as a pain that continues for twelve weeks or longer, even after an initial injury or primary cause of acute low back pain has been treated. Lower back pain that is long-term is called chronic back pain, this condition might create from a disease, injury, or stress on different structures of the body, and pain may vary considerably and may be felt as nerve pain, muscle pain, or bone pain. Pain hardness may form a bi-dimensional or a one-dimensional scale depending on the particular devices tested. High inter-correlations between pain-intensity measures and pain-related disability measures support the concept of using them as a unitary construct of pain severity. Experts use different scales to assess the severity of pain in CLBP patients; two of the most widely used are Visual Analogue Scale and Verbal Rating Scale.
Market Dynamics
The market is mainly driven by the rising occurrence of nerve cases, and the growing old population is the significant driver behind the growth of the market. In addition to this, hectic and inactive lifestyles, rising disposable income, along increasing healthcare awareness are the factor that is likely to boost the market. However, the unavailability of the proper medication and poor medication results may hamper the growth of the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of chronic back pain. The growth and trends of chronic back pain industry provide a holistic approach to this study.
Market Segmentation
This section of the chronic back pain market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type of Pain
- Diskogenic Pain
- Lumbar Spinal Stenosis
- Sacroiliac Pain
- Facet-Joint Pain
- Others
By Diagnosis
- Clinical History
- Physical Examination
- Imaging Guidelines
- Assessment of Pain
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Chronic Back Pain market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Chronic Back Pain Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the chronic back pain market include Johnson & Johnson Services Inc., Pfizer Inc., Sanofi, Endo Pharmaceuticals Inc., Merck & Co., Inc., Vertebral Technologies, Inc., Medtronic, Boston Scientific Corporation, Bio Wave Corporation, and Koninklijke Philips N.V. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.